ライフサイエンスコーパス: MOCA

1 MOCA accumulates during neuronal differentiation, and it

2 MOCA can also be used in terrestrial settings for on-sit

3 MOCA can use the perchlorate present in the Martian soil

4 MOCA colocalizes with N-cadherin and actin in areas of c

5 MOCA increases the accumulation of adherens junction pro

6 MOCA is associated with Alzheimer's disease tangles and

7 MOCA is designed as a small, lightweight, low-power inst

8 ged in the form of mechanochemical ablation (MOCA) and cyanoacrylate adhesive injection (CAE).

9 en associated with gamma-secretase activity, MOCA may be involved in the regulation of beta-amyloid p

10 Modifier of cell adhesion (MOCA) is a member of the dedicator of cytokinesis 180 fa

11 Modifier of cell adhesion (MOCA) is a presenilin binding protein that functions as

12 e Organization of Combinatorial Alterations (MOCA), to partially address these challenges.

13 e organization of combinatorial alterations (MOCA), we defined a novel biliary vesicle miR-based pane

14 designated the Mars Organic Carbon Analyzer (MOCA).

15 Both EVLA and MOCA were highly efficacious in treating SVI; patients i

16 and quality of life outcomes after EVLA and MOCA.

17 symptoms) and Montreal Cognitive Assessment (MOCA) score of 18 or higher (range, 0-30).

18 Montreal cognitive assessments (MOCA), Karnofsky performance scores, magnetic resonance

19 Montreal Cognitive Assessments (MOCA), Karnofsky Performance scores, MRI brain scanning,

20 resulting 'mouse organogenesis cell atlas' (MOCA) provides a global view of developmental processes

21 The phenotypic changes caused by MOCA are due to an acceleration in the rate of intracell

22 In contrast, MOCA does not lower the secretion of amyloid precursor-l

23 A was 22 (9-44) compared to 15 (9-29) during MOCA; P = 0.210.

24 competence were randomized to receive either MOCA or CAE.

25 nd beta-catenin, whereas reducing endogenous MOCA expression lowers cell-cell aggregation and N-cadhe

26 Furthermore, MOCA deficiency causes an alteration in the actin cytosk

27 The dystrophic axons found in MOCA-deficient mice are associated with abnormal aggrega

28 nts demonstrated significant improvements in MOCA and Karnofsky scores at 1 month (P < .0003), which

29 nts demonstrated significant improvements in MOCA and Karnofsky scores at 1 month (p<0.0003), which w

30 stics were balanced across groups, including MOCA score (mean [SD], drug, 23.9 [3.1]; behavioral, 24.

31 cell adhesion is a downstream consequence of MOCA-directed APP catabolism.

32 The effect of MOCA expression on the secretion of APP and cellular adh

33 ole in APP metabolism and that the effect of MOCA on APP secretion and cell adhesion is a downstream

34 Here we show that the expression of MOCA decreases both APP and amyloid beta-peptide secreti

35 The loss of MOCA in mice leads to axonal degeneration and causes sen

36 ts were equally randomized to either EVLA or MOCA, both with concomitant phlebectomy when necessary.

37 Modifier of cell adhesion protein (MOCA; previously called presenilin [PS] binding protein)

38 [9.0-42.0] mm; P = .23) or by number scale (MOCA, 4 [2-5] vs CAE, 3 [2-4]; P = .18).

39 Through a series of proof-of-concept tests, MOCA is shown to oxidize a variety of low-molecular-weig

40 We conclude that MOCA regulates N-cadherin-mediated cell-cell adhesion an

41 It is concluded that MOCA plays a major role in APP metabolism and that the e

42 These findings demonstrate that MOCA is required for maintaining the functional integrit

43 Here, we report that MOCA modulates cell-cell adhesion and morphology.

44 ed by proteasome inhibitors, suggesting that MOCA directs nascent APP to proteasomes for destruction.

45 One patient in the MOCA group experienced DVT.

46 e 63/69 (91%) compared to 53/69 (77%) in the MOCA group; P = 0.020.

47 The study demonstrated that the MOCA and CAE techniques have a similar periprocedural pa

48 erence in median (IQR) pain measured by VAS (MOCA, 24 [11.5-44.7] mm vs CAE, 20 [9.0-42.0] mm; P = .2